↓ Skip to main content

TSC2-deficient tumors have evidence of T cell exhaustion and respond to anti–PD-1/anti–CTLA-4 immunotherapy

Overview of attention for article published in JCI Insight, April 2018
Altmetric Badge

Mentioned by

twitter
2 X users

Citations

dimensions_citation
52 Dimensions

Readers on

mendeley
52 Mendeley